BlackRock’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113M | Buy |
|
|||||
|
2025
Q1 | $100M | Buy |
|
|||||
|
2024
Q4 | $138M | Buy |
|
|||||
|
2024
Q3 | $166M | Buy |
|
|||||
|
2024
Q2 | $174M | Buy |
|
|||||
|
2024
Q1 | $189M | Buy |
|
|||||
|
2023
Q4 | $146M | Buy |
|
|||||
|
2023
Q3 | $89.5M | Buy |
|
|||||
|
2023
Q2 | $109M | Sell |
|
|||||
|
2023
Q1 | $117M | Buy |
|
|||||
|
2022
Q4 | $144M | Buy |
|
|||||
|
2022
Q3 | $88M | Sell |
|
|||||
|
2022
Q2 | $85M | Buy |
|
|||||
|
2022
Q1 | $104M | Sell |
|
|||||
|
2021
Q4 | $120M | Sell |
|
|||||
|
2021
Q3 | $169M | Buy |
|
|||||
|
2021
Q2 | $90.3M | Buy |
|
|||||
|
2021
Q1 | $19.9M | Buy |
|
|||||
|
2020
Q4 | $15.1M | Buy |
|
|||||
|
2020
Q3 | $11.7M | Buy |
|
|||||
|
2020
Q2 | $5.36M | Buy |
|
|||||
|
2020
Q1 | $572K | Buy |
|
|||||
|
2019
Q4 | $763K | Sell |
|
|||||
|
2019
Q3 | $729K | Buy |
|
|||||
|
2019
Q2 | $914K | Buy |
|
|||||
|
2019
Q1 | $1.49M | Buy |
|
|||||
|
2018
Q4 | $370K | Sell |
|
|||||
|
2018
Q3 | $1.72M | Buy |
|
|||||
|
2018
Q2 | $1.8M | Sell |
|
|||||
|
2018
Q1 | $23.5M | Buy |
|
|||||
|
2017
Q4 | $28.2M | Buy |
|
|||||
|
2017
Q3 | $27.6M | Buy |
|
|||||
|
2017
Q2 | $23.1M | Buy |
|
|||||
|
2017
Q1 | $29.3M | Buy |
|
|||||
|
2016
Q4 | $84K | Buy |
|
|||||
|
2016
Q3 | $91K | Buy |
|
|||||
|
2016
Q2 | $98K | Buy |
|
|||||
|
2016
Q1 | $25K | Buy |
|
|||||
|
2015
Q4 | $44K | Buy |
|
|||||
|
2015
Q3 | $26K | Hold |
|
|||||
|
2015
Q2 | $61K | Sell |
|
|||||
|
2015
Q1 | $70K | Sell |
|
|||||
|
2014
Q4 | $48K | Hold |
|
|||||
|
2014
Q3 | $34K | Hold |
|
|||||
|
2014
Q2 | $43K | Buy |
|
|||||
|
2014
Q1 | $39K | Sell |
|
|||||
|
2013
Q4 | $68K | Buy |
|
|||||
|
2013
Q3 | $97K | Hold |
|
|||||
|
2013
Q2 | $43K | Buy |
|